249 related articles for article (PubMed ID: 31301971)
1. Interactions between artemisinin derivatives and P-glycoprotein.
Wang Y; Li Y; Shang D; Efferth T
Phytomedicine; 2019 Jul; 60():152998. PubMed ID: 31301971
[TBL] [Abstract][Full Text] [Related]
2. 10-Phenyltriazoyl Artemisinin is a Novel P-glycoprotein Inhibitor that Suppresses the Overexpression and Function of P-glycoprotein.
Lee DH; Hasanuzzaman M; Kwon D; Choi HY; Kim SM; Kim DJ; Kang DJ; Hwang TH; Kim HH; Shin HJ; Shin JG; Oh S; Lee S; Kim SW
Curr Pharm Des; 2018; 24(46):5590-5597. PubMed ID: 30799787
[TBL] [Abstract][Full Text] [Related]
3. A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency.
Lin R; Zhang L; Ye B; Wang Y; Li YD; Jason H; Liu W; Hu P; Chen J; Chen ZS; Chen Z
Cancer Lett; 2023 Jun; 563():216181. PubMed ID: 37086953
[TBL] [Abstract][Full Text] [Related]
4. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
5. Zhankuic Acids A, B and C from
Teng YN; Wang YH; Wu TS; Hung HY; Hung CC
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31766413
[No Abstract] [Full Text] [Related]
6. The Effects of Traditional Chinese Medicine on P-Glycoprotein-Mediated Multidrug Resistance and Approaches for Studying the Herb-P-Glycoprotein Interactions.
Cao Y; Shi Y; Cai Y; Hong Z; Chai Y
Drug Metab Dispos; 2020 Oct; 48(10):972-979. PubMed ID: 32816867
[TBL] [Abstract][Full Text] [Related]
7. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.
Binkhathlan Z; Lavasanifar A
Curr Cancer Drug Targets; 2013 Mar; 13(3):326-46. PubMed ID: 23369096
[TBL] [Abstract][Full Text] [Related]
9. Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review.
Dong J; Yuan L; Hu C; Cheng X; Qin JJ
Pharmacol Ther; 2023 Sep; 249():108488. PubMed ID: 37442207
[TBL] [Abstract][Full Text] [Related]
10. Glucosamine Reverses P-Glycoprotein-Mediated Multidrug Resistance in the Daunorubicin-Resistant Human Gastric Cancer Cells.
Valinezhad Sani F; Mosaffa F; Jamialahmadi K; Palizban A
Nutr Cancer; 2020; 72(3):522-527. PubMed ID: 31290701
[TBL] [Abstract][Full Text] [Related]
11. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells.
Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC
Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy.
Breier A; Barancík M; Sulová Z; Uhrík B
Curr Cancer Drug Targets; 2005 Sep; 5(6):457-68. PubMed ID: 16178819
[TBL] [Abstract][Full Text] [Related]
13. Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp).
Zhang H; Xu H; Ashby CR; Assaraf YG; Chen ZS; Liu HM
Med Res Rev; 2021 Jan; 41(1):525-555. PubMed ID: 33047304
[TBL] [Abstract][Full Text] [Related]
14. Phytochemicals reverse P-glycoprotein mediated multidrug resistance via signal transduction pathways.
Ganesan M; Kanimozhi G; Pradhapsingh B; Khan HA; Alhomida AS; Ekhzaimy A; Brindha GR; Prasad NR
Biomed Pharmacother; 2021 Jul; 139():111632. PubMed ID: 34243600
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
Pérez-Tomás R
Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
[TBL] [Abstract][Full Text] [Related]
16. Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer.
Halder J; Pradhan D; Kar B; Ghosh G; Rath G
Nanomedicine; 2022 Feb; 40():102494. PubMed ID: 34775061
[TBL] [Abstract][Full Text] [Related]
17. Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.
De Vera AA; Gupta P; Lei Z; Liao D; Narayanan S; Teng Q; Reznik SE; Chen ZS
Cancer Lett; 2019 Feb; 442():91-103. PubMed ID: 30391357
[TBL] [Abstract][Full Text] [Related]
18. SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells.
Xu SW; Law BYK; Qu SLQ; Hamdoun S; Chen J; Zhang W; Guo JR; Wu AG; Mok SWF; Zhang DW; Xia C; Sugimoto Y; Efferth T; Liu L; Wong VKW
Pharmacol Res; 2020 Mar; 153():104660. PubMed ID: 31982489
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological strategies for overcoming multidrug resistance.
Nobili S; Landini I; Giglioni B; Mini E
Curr Drug Targets; 2006 Jul; 7(7):861-79. PubMed ID: 16842217
[TBL] [Abstract][Full Text] [Related]
20. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
